We therefore evaluated the interaction of CD227 against two mucin-expressing human pancreatic cancer cell lines (Capan-1 and HPAF-II), and one (non-mucin expressing) human glioblastoma (U-87 MG) cell line as a negative control. The gene discussed is MUC5AC; the disease is pancreatic neoplasm.